Cardiac manifestations in sickle cell disease varies with patient genotype

Paul Guedeney1, François Lionnet2, Alexandre Ceccaldi1

  • 1Sorbonne Universités, UPMC Univ Paris 06, Institut de Cardiologie (AP-HP), Centre Hospitalier Universitaire Pitié-Salpêtrière, Institute of Cardiometabolism and Nutrition (ICAN), INSERM UMRS 1166, ACTION Study Group, Paris, France.

Insights

Cardiac involvement differs between sickle cell anaemia (SCA) and Haemoglobin SC (HbSC) disease. SCA shows more left ventricular hypertrophy, while HbSC disease

Area of Science:

  • Cardiology
  • Hematology
  • Genetics

Background:

  • Cardiac involvement is well-defined in sickle cell anaemia (SCA).
  • Cardiac manifestations in Haemoglobin SC (HbSC) disease remain largely uncharacterized.
  • Understanding genotypic differences in cardiac complications is crucial for patient management.

Purpose of the Study:

  • To compare cardiac features in patients with HbSC disease versus SCA patients.
  • To identify determinants of cardiac involvement in both sickle cell genotypes.
  • To establish genotype-specific echocardiographic findings and indications.

Main Methods:

  • Echocardiography was used to assess left ventricular ejection fraction (LVEF), left ventricle mass index (LVMi), cardiac index, and peak tricuspid regurgitation velocity (TRV).
  • LV filling pressures were evaluated using the E/e' ratio.
  • Sixty HbSC patients were compared to 60 SCA patients and 60 age/gender-matched controls.

Main Results:

  • Both HbSC and SCA patients showed higher LVMi than controls; LV hypertrophy was significantly more prevalent in SCA (45%) than HbSC (5%).
  • SCA patients had elevated cardiac index and TRV, while HbSC patients' cardiac index and TRV were similar to controls.
  • Both genotypes exhibited higher E/e' ratios than controls, indicating diastolic dysfunction. In SCA, cardiac involvement correlated with anaemia/haemolysis; in HbSC, it linked to hypertension/obesity.

Conclusions:

  • Cardiac involvement and its underlying causes differ significantly between HbSC disease and SCA.
  • SCA is associated with more pronounced left ventricular hypertrophy.
  • Genotype-specific considerations are essential for echocardiographic assessment and interpretation in sickle cell disorders.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
683
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
667
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
458
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
643
Gradually Varying Flow01:29

Gradually Varying Flow

Gradually varying flow (GVF) in open channels describes situations where water depth changes slowly along the channel due to factors like non-uniform bed slope, channel shape variations, or obstructions. This flow type occurs when the depth adjusts gradually to balance gravitational forces, shear forces, and energy requirements, resulting in a low rate of depth change.Characteristics of Gradually Varying FlowGVF is commonly observed in natural streams, rivers, and canals, where flow depth...
451